Neurodegenerative diseases

Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

2026/03/03 - 10:00 AM EST / 16:00 CET
1 hour

Join us for the second session in a series of webinars dedicated to promising neuro biomarkers.

Register here

Our webinar series about promising neuro biomarkers

In this edition, Dr. Giovanni Bellomo and Dr. Patrick Öckl will discuss how emerging synaptic biomarkers, such as β synuclein, contribute to our understanding of different neuronal pathologies. 

The webinar is moderated by Dr. Shreyasee Das from ADx NeuroSciences, a Fujirebio company.

Reserve your seat today

Starts on 2026/03/03 - 10:00 AM EST / 16:00 CET Duration: 1 hour
Register here

The speakers

Dr. Giovanni Bellomo

Sant Pau Research Institute in Barcelona, Spain. Focuses on development of novel diagnostic and therapeutic tools for neurodegenerative diseases and psychiatric disorders through biomarker development and mechanistic studies of synapse degeneration and inflammation.

Dr. Belbin's Neuro Biomarker Talk:
Impact of Alzheimer’s comorbidity on synaptic biomarkes in dementia with Lewy bodies.

Dr. Patrick Öckl

UMC, Amsterdam, the Netherlands. Focuses on fluid biomarkers for dementia with Lewy bodies, particularly their validation and the development of new assays to enhance detection and understanding of the disease.

Dr. Bolsewig's Neuro Biomarker Talk:
DOPA Decarboxylase - an emerging fluid biomarker for LBDs.

The webinar is moderated by Dr. Shreyasee Das from ADx NeuroSciences, a Fujirebio company.

For whom this webinar is intended

This session is open for all, but was designed for the following professions engaged in neurodegenerative disease research with a focus on neurodegenerative disorders characterized by synaptic and dopaminergic dysfunction:

  • Researchers
  • Pharmaceutical professionals
  • Biotechnology professionals
  • CROs (Contract Research Organizations)
  • Technology providers

 

Reserve your seat today

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.